ORAL MEDICINE

口服药

• 批准号: 3938023
• 负责人: MARK SCHUBERT
• 金额: --
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3938023
• 关键词: Candida albicans; Staphylococcus; antifungal agents; antiviral agents; aspergillosis; biomedical facility; bone marrow transplantation; cancer pain; chlorine; communicable disease diagnosis; dental disorder; graft versus host disease; gram negative bacteria; human subject; immunosuppression; microorganism classification; microorganism disease chemotherapy; oral bacteria; oral facial pain; oral pharyngeal disorder diagnosis; steroid hormone

Members of the Oral Medicine Team provide pretransplant evaluations with appropriate prophylactic interventions. They provide care for hospitalized patients with dental problems. They perform repeat evaluations prior to departure from Seattle and make appropriate recommendations for continued oral care. Oral pathobiology studies include an evaluation of changes in mouth flora and the impact of these changes on the clinical course. Oral hygiene protocols will be evaluated as will the benefits of topical oral antiseptic agents. The studies of the oral changes associated with chronic GVHD will be continued including the study of topical steroid application.

口腔医学团队的成员提供移植前 进行适当的预防性干预。 他们 为有牙齿问题的住院病人提供护理。 他们 在从西雅图起飞前进行重复评估， 提出持续口腔护理的适当建议。 口腔病理生物学研究包括评估 口腔植物群及其变化对临床的影响 当然了 将对口腔卫生方案进行评估， 局部口腔防腐剂的好处。 口腔医学研究 与慢性GVHD相关的变化将继续进行，包括 局部类固醇应用的研究。